AR protein in prostate cancer detected with new imaging technique

Researchers have developed a new imaging technique that can identify variants of the androgen receptors that do not respond to current androgen-deprivation therapies. The discovery could lead to better clinical management of patients with castration-resistant prostate cancer (CRPC). Read more.